Bipartisan Policy Center
1225 Eye Street NW, Suite 1000
Washington, D.C. xxxxxx Get Directions
Can't join us in person?Bookmark this link to watch the live webcast.
Dr. Peter Bach | Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
Mark Boutin | CEO, National Health Council
David Henka| President & CEO, ActiveRADAR
Avik Roy| President, Foundation of Research on Equal Opportunity
Dr. Sabine Vogler| Head of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies
Additional Participants to be announced.
Reflecting the American public’s concerns about access to necessary medications, Congress and the Trump administration have proposed various policies to curb high drug prices. The Bipartisan Policy Center set out to explore the implications of using pharmaceutical reference pricing – both internal and external – in the United States. Both types of reference pricing are used commonly in other countries to mitigate the high prices of drugs. Please join us as we release a report on our findings and host policymakers and experts to discuss potential policy solutions which address the high costs of drugs in the United States.
Bipartisan Policy Center
1225 Eye Street NW, Suite 1000, Washington, D.C. xxxxxx
(202) 204-2400 | bipartisanpolicy.org
